The “E” in Cost-Effectiveness Analyses. A Case Study of Omalizumab Efficacy and Effectiveness for Cost-Effectiveness Analysis Evidence
2014 ◽
Vol 11
(Supplement 2)
◽
pp. S105-S111
◽
Keyword(s):
2006 ◽
Vol 91
(1-2)
◽
pp. 73-89
◽
2019 ◽
Vol 21
(2)
◽
pp. 235-249
◽
2009 ◽
Vol 4
(1-3)
◽
pp. 22-27
◽
2004 ◽
Vol 1866
(1)
◽
pp. 9-19
◽